이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Patrys 관리

관리 기준 확인 2/4

Patrys' CEO는 James Campbell, Apr2015 에 임명되었습니다 의 임기는 9.17 년입니다. 총 연간 보상은 A$ 735.44K, 48.7% 로 구성됩니다. 48.7% 급여 및 51.3% 보너스(회사 주식 및 옵션 포함). 는 A$ 132.20K 가치에 해당하는 회사 주식의 0.92% 직접 소유합니다. 132.20K. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 6.1 년입니다.

주요 정보

James Campbell

최고 경영자

AU$735.4k

총 보상

CEO 급여 비율	48.7%
CEO 임기	9.3yrs
CEO 소유권	0.9%
경영진 평균 재임 기간	2.8yrs
이사회 평균 재임 기간	6.2yrs

최근 관리 업데이트

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

CEO 보상 분석

James Campbell 의 보수는 Patrys 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$6m
Jun 30 2023	AU$735k	AU$358k	-AU$7m
Mar 31 2023	n/a	n/a	-AU$7m
Dec 31 2022	n/a	n/a	-AU$6m
Sep 30 2022	n/a	n/a	-AU$6m
Jun 30 2022	AU$718k	AU$327k	-AU$7m
Mar 31 2022	n/a	n/a	-AU$7m
Dec 31 2021	n/a	n/a	-AU$7m
Sep 30 2021	n/a	n/a	-AU$5m
Jun 30 2021	AU$601k	AU$325k	-AU$4m
Mar 31 2021	n/a	n/a	-AU$4m
Dec 31 2020	n/a	n/a	-AU$3m
Sep 30 2020	n/a	n/a	-AU$3m
Jun 30 2020	AU$434k	AU$318k	-AU$3m
Mar 31 2020	n/a	n/a	-AU$3m
Dec 31 2019	n/a	n/a	-AU$3m
Sep 30 2019	n/a	n/a	-AU$2m
Jun 30 2019	AU$504k	AU$305k	-AU$411k
Mar 31 2019	n/a	n/a	-AU$511k
Dec 31 2018	n/a	n/a	-AU$611k
Sep 30 2018	n/a	n/a	-AU$2m
Jun 30 2018	AU$399k	AU$280k	-AU$2m

보상 대 시장: James 의 총 보상 ($USD 490.62K )은 Australian 시장( $USD 298.77K ).

보상과 수익: 회사가 수익성이 없는 동안 James 의 보상이 증가했습니다.

CEO

James Campbell

9.3yrs

테뉴어

AU$735,443

보상

Dr. James A. Campbell, BSc(Hons), PhD, MBA, GAICD, serves as Chief Executive Officer and Managing Director for Patrys Limited since April 13, 2015. Dr. Campbell serves as Principal of Gemini Biotechnology....

리더십 팀

이름	위치	테뉴어	보상	소유권
James Campbell	MD, CEO & Executive Director	9.3yrs	AU$735.44k	0.92% A$ 132.2k
Stefan Ross	Company Secretary	2.8yrs	AU$12.67k	데이터 없음
Rebecca Tunstall	Vice President of Corporate Development	2.2yrs	데이터 없음	데이터 없음

2.8yrs

평균 재임 기간

경험이 풍부한 관리: PAB 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
James Campbell	MD, CEO & Executive Director	9.7yrs	AU$735.44k	0.92% A$ 132.2k
Pamela M. Klein	Non-Executive Director	4.8yrs	AU$90.52k	0.012% A$ 1.7k
Peter Ordentlich	Member of Scientific Advisory Board	4.2yrs	데이터 없음	데이터 없음
Michael Stork	Non-Executive Director	17.4yrs	AU$1.25k	4.8% A$ 691.4k
Allen Ebens	Member of Scientific Advisory Board	7.6yrs	데이터 없음	데이터 없음
Charmaine Gittleson	Chairman	1.7yrs	AU$83.77k	데이터 없음

6.2yrs

평균 재임 기간

경험이 풍부한 이사회: PAB 의 이사회는 경험(평균 재직 기간 6.1 년)으로 간주됩니다.

Patrys 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Patrys Limited, Annual General Meeting, Nov 15, 2023

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Recent updates

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간